Jyong Biotech MENS
NASDAQ MENS
$1.77 +0.03 (+1.72%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Short-term Investments (2025)

Updated

Jyong Biotech's Short-term Investments came in at $16.88 million for the quarter ended Jun 30, 2025.

Analysis

Jyong Biotech (MENS) Short-term Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Jyong Biotech 129.23 Mn 129.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 16.88 Mn
API Access

Jyong Biotech Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=MENS&period=max&api_key=YOUR_API_KEY